AYTU BIOPHARMA INC's ticker is AYTU and the CUSIP is 054754874. A total of 61 filers reported holding AYTU BIOPHARMA INC in Q2 2021. The put-call ratio across all filers is 0.63 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $225 | -99.7% | 1,189,958 | +190.3% | 0.00% | – |
| Q3 2022 | $76,000 | -37.2% | 409,842 | +134.5% | 0.00% | – |
| Q2 2022 | $121,000 | -57.8% | 174,797 | -34.3% | 0.00% | – |
| Q1 2022 | $287,000 | -28.1% | 265,917 | -10.1% | 0.00% | – |
| Q4 2021 | $399,000 | -61.6% | 295,779 | -17.9% | 0.00% | -100.0% |
| Q3 2021 | $1,038,000 | -52.9% | 360,256 | -18.2% | 0.00% | 0.0% |
| Q2 2021 | $2,206,000 | – | 440,415 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 2,379,936 | $2,570,000 | 0.05% |
| HUNTER ASSOCIATES INVESTMENT MANAGEMENT LLC | 10,880 | $12,000 | 0.00% |
| Renaissance Technologies | 765,469 | $827,000 | 0.00% |
| SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC | 53,530 | $58,000 | 0.00% |
| Focused Wealth Management, Inc | 209 | $0 | 0.00% |
| FEDERATED HERMES, INC. | 5,633 | $6,000 | 0.00% |
| JANICZEK WEALTH MANAGEMENT, LLC | 1 | $0 | 0.00% |
| UBS Group AG | 1 | $0 | 0.00% |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | 100 | $0 | 0.00% |
| IFP Advisors, Inc | 2,400 | $16,000 | 0.00% |